Know Cancer

or
forgot password

Cancer Center Trials: Reasons for Low Accrual Rates at One Academic Institution Vs. The Community Setting


N/A
18 Years
N/A
Not Enrolling
Female
Cancer

Thank you

Trial Information

Cancer Center Trials: Reasons for Low Accrual Rates at One Academic Institution Vs. The Community Setting


Objective 1: All new cancer patients seen for a four month period at the University of New
Mexico Cancer Research and Treatment Center (UNM CRTC) (academic population) and for a six
month-period at the New Mexico Cancer Care Alliance (NMCCA) (community setting). A careful
screening log will be kept during this period with the research nurses cooperation in
documenting 1) whether patients seen were accrued to a clinical trial, 2) what available
trials the patient might possibly be eligible for, and 3) the reason for not registering on
to a clinical trial.

Objective 2: To compare the responses to questions on the entry forms of those women who
were eligible and declined participation to those who participated by Hispanic versus
non-Hispanic ethnicity, we will access, copy, and analyze all the risk assessment profiles
otherwise known as entry or eligibility forms completed by women who considered
participating in the study of Tamoxifen and Raloxifene (STAR). Patterns of eligibility
criteria and risk assessment will be described by ethnicity of women considered for entry
into this chemopreventive randomized trial without the use of personal identifying data in
accordance with the Health Insurance Portability Accountability Act of 1996 to maintain
patient confidentiality


Inclusion Criteria:



- Women who considered participating in the study of Tamoxifen and Raloxifene (STAR)
for the prevention of breast cancer in high risk women through the University of New
Mexico in Albuquerque from 1999 through 2004

Exclusion Criteria:

- Not specified.

Type of Study:

Observational

Study Design:

Observational Model: Ecologic or Community, Time Perspective: Retrospective

Principal Investigator

Claire Verschraegen, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of New Mexico

Authority:

United States: Institutional Review Board

Study ID:

4904C

NCT ID:

NCT00322647

Start Date:

January 2005

Completion Date:

June 2007

Related Keywords:

  • Cancer

Name

Location

University of New MexicoAlbuquerque, New Mexico  87131